Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bile Duct Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Not applicableEnded earlyNCT04276090
What this trial is testing

Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct NeoplasmsColorectal Neoplasms
Michael J Cavnar, MD 21
Not applicableStudy completedNCT05429203
What this trial is testing

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Who this might be right for
Biliary DiseasePancreatic DiseaseCholedocholithiasis+3 more
Stanford University 319
Testing effectiveness (Phase 2)Active Not RecruitingNCT05564403
What this trial is testing

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Gallbladder CarcinomaAdvanced Intrahepatic Cholangiocarcinoma+14 more
National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Not applicableWithdrawnNCT00588263
What this trial is testing

Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+7 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03044587
What this trial is testing

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer

Who this might be right for
Adenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more
AIO-Studien-gGmbH 93
Not applicableUnknownNCT05418543
What this trial is testing

CH-EUS in Diagnosis of Inoperable Bile Duct Tumors

Who this might be right for
Inoperable DiseaseBile Duct Cancer
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor 40
Testing effectiveness (Phase 2)UnknownNCT05911425
What this trial is testing

Combined Treatment of Treated Bile Duct Cancer

Who this might be right for
Bile Duct Cancer
Zhejiang Cancer Hospital 30
Not applicableUnknownNCT02611453
What this trial is testing

Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP

Who this might be right for
CholedocholithiasisBile Duct DiseasesBile Duct Carcinoma
University of Virginia 40
Testing effectiveness (Phase 2)Study completedNCT00033540
What this trial is testing

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
SWOG Cancer Research Network 57
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238637
What this trial is testing

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 50
Not applicableStudy completedNCT00587236
What this trial is testing

Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis

Who this might be right for
Colitis, UlcerativeCholangitis, Sclerosing
Mayo Clinic 65
Not applicableStudy completedNCT06903520
What this trial is testing

Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System

Who this might be right for
Pancreaticobiliary Maljunction
Chinese PLA General Hospital 2,439
Not applicableStudy completedNCT06887023
What this trial is testing

Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB

Who this might be right for
Bile Duct Neoplasms Malignant
The First Hospital of Jilin University 118
Not applicableLooking for participantsNCT04753996
What this trial is testing

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

Who this might be right for
Primary Sclerosing CholangitisPSCCholangiocarcinoma
Mayo Clinic 300
Testing effectiveness (Phase 2)Study completedNCT00084942
What this trial is testing

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
Roswell Park Cancer Institute
Not applicableNot Yet RecruitingNCT07716345
What this trial is testing

Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 100
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Next Page